Warfarin and acenocoumarol dose requirements according to cyp2c9genotyping in north-Italian patients

M. Spreafico; F. Peyvandi; D. Pizzotti; M. Moia; P. M. Mannucci

doi:10.1046/j.1538-7836.2003.00442.x

Warfarin and acenocoumarol dose requirements according to cyp2c9genotyping in north-Italian patients

M. Spreafico, F. Peyvandi, D. Pizzotti, M. Moia, P. M. Mannucci

Fondazione IRCCS Ca' Granda- Ospedale Maggiore Policlinico

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2252-2253
Number of pages	2
Journal	Journal of Thrombosis and Haemostasis
Volume	1
Issue number	10
DOIs	https://doi.org/10.1046/j.1538-7836.2003.00442.x
Publication status	Published - Oct 2003

ASJC Scopus subject areas

Hematology
Medicine(all)

Access to Document

10.1046/j.1538-7836.2003.00442.x

Cite this

@article{2863f21cf48341a4b18ebe3ebf8374e8,

title = "Warfarin and acenocoumarol dose requirements according to cyp2c9genotyping in north-Italian patients",

author = "M. Spreafico and F. Peyvandi and D. Pizzotti and M. Moia and Mannucci, {P. M.}",

year = "2003",

month = oct,

doi = "10.1046/j.1538-7836.2003.00442.x",

language = "English",

volume = "1",

pages = "2252--2253",

journal = "Journal of Thrombosis and Haemostasis",

issn = "1538-7933",

publisher = "Wiley-Blackwell",

number = "10",

}

TY - JOUR

T1 - Warfarin and acenocoumarol dose requirements according to cyp2c9genotyping in north-Italian patients

AU - Spreafico, M.

AU - Peyvandi, F.

AU - Pizzotti, D.

AU - Moia, M.

AU - Mannucci, P. M.

PY - 2003/10

Y1 - 2003/10

UR - http://www.scopus.com/inward/record.url?scp=3042786315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042786315&partnerID=8YFLogxK

U2 - 10.1046/j.1538-7836.2003.00442.x

DO - 10.1046/j.1538-7836.2003.00442.x

M3 - Article

C2 - 14521618

AN - SCOPUS:3042786315

VL - 1

SP - 2252

EP - 2253

JO - Journal of Thrombosis and Haemostasis

JF - Journal of Thrombosis and Haemostasis

SN - 1538-7933

IS - 10

ER -

Warfarin and acenocoumarol dose requirements according to cyp2c9genotyping in north-Italian patients

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this